Healthcare Innovation January 6, 2023
Geert De Lombaerde

The pharmacy giant’s leaders say their healthcare services group should produce about $7 billion in sales this year.

On the heels of an M&A binge since the fall of 2021, Walgreens Boots Alliance’s moves to further grow its healthcare services lineup will be more tactical in the quarters ahead, CFO James Kehoe said Jan. 5.

“We’re taking a pause. We need to focus on integration activities,” Kehoe said on a conference call discussing Walgreen’s results for the three months ended Nov. 30. “We’re not going to go out and do a $2 billion or $3 billion acquisition of a health tech company. We’re likely to be very targeted, and it will be in the hundreds of millions, not in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Post-Acute Care, Primary care, Provider, Specialist care, Trends
Related Articles:
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices

Share This Article